Published online Jan 26, 2024. doi: 10.4330/wjc.v16.i1.27
Peer-review started: November 29, 2023
First decision: December 12, 2023
Revised: December 14, 2023
Accepted: January 3, 2024
Article in press: January 3, 2024
Published online: January 26, 2024
Processing time: 51 Days and 1.7 Hours
Lack of mobilization and prolonged stay in the intensive care unit (ICU) are major factors resulting in the development of ICU-acquired muscle weakness (ICUAW). Early mobilization in the ICU after cardiac surgery is associated with a reduced duration of mechanical ventilation and ICU length of stay.
Neuromuscular electrical stimulation (NMES) is an alternative modality of exercise in patients with muscle weakness. A major advantage of NMES is that it can be applied even in sedated patients in the ICU, a fact that might enhance early mobilization in these patients.
To evaluate safety, feasibility and effectiveness of NMES on functional capacity and muscle strength in patients before and after cardiac surgery.
We performed a search on Pubmed, PEDro, Embase and CINAHL databases, selecting papers published between December 2012 and April 2023 and identified published randomized controlled trials (RCTs) that included implementation of NMES in patients before after cardiac surgery. RCTs were assessed for methodological rigor and risk of bias via the Physiotherapy Evidence Database. The primary outcomes were safety and functional capacity and the secondary outcomes were muscle strength and function.
Ten studies were included in our systematic review, resulting in 703 participants. Almost half of them performed NMES and the other half were included in the control group, treated with usual care. Nine studies investigated patients after cardiac surgery and 1 study before cardiac surgery. Functional capacity was assessed in 8 studies via 6MWT or other indices, and improved only in 1 study before and in 1 after cardiac surgery. Nine studies explored the effects of NMES on muscle strength and function and, most of them, found increase of muscle strength and improvement in muscle function after NMES. NMES was safe in all studies without any significant complication.
NMES is safe, feasible and has beneficial effects on muscle strength and function in patients after cardiac surgery, but has no significant effect on functional capacity.
The present systematic review evaluated the beneficial effects of NMES on functional capacity, muscle strength and muscle function. NMES should be initiated in patients as a form of prehabilitation before a major cardiac surgery and be continued immediately after the surgery until hospital discharge. A multidisciplinary team approach is necessary for its implementation. Preventing ICUAW and polyneuromyopathy via NMES could result in better prognosis, reduced length of stay in the ICU, less complications and improved exercise tolerance and mobility of cardiac surgery patients.